WO2008064138A3 - Personalized therapeutic treatment process - Google Patents

Personalized therapeutic treatment process Download PDF

Info

Publication number
WO2008064138A3
WO2008064138A3 PCT/US2007/085033 US2007085033W WO2008064138A3 WO 2008064138 A3 WO2008064138 A3 WO 2008064138A3 US 2007085033 W US2007085033 W US 2007085033W WO 2008064138 A3 WO2008064138 A3 WO 2008064138A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment process
therapeutic treatment
personalized therapeutic
personalized
chemical
Prior art date
Application number
PCT/US2007/085033
Other languages
French (fr)
Other versions
WO2008064138A2 (en
Inventor
Ali Arjomand
Glenn Kawasaki
Michael Chansler
Original Assignee
Accium Biosciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accium Biosciences filed Critical Accium Biosciences
Priority to CN200780050039A priority Critical patent/CN101702921A/en
Priority to EP07864570A priority patent/EP2094861A4/en
Priority to BRPI0719314-9A priority patent/BRPI0719314A2/en
Priority to AU2007323782A priority patent/AU2007323782A1/en
Priority to JP2009537402A priority patent/JP2010510495A/en
Priority to CA002669864A priority patent/CA2669864A1/en
Publication of WO2008064138A2 publication Critical patent/WO2008064138A2/en
Publication of WO2008064138A3 publication Critical patent/WO2008064138A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns

Abstract

There is disclosed a process for simultaneous determination of the delivery of two or more chemical (therapeutic) agents to diseased tissue. The procedure generates a patient-specific report that is used to select the best chemical agent and dosage on a personalized basis.
PCT/US2007/085033 2006-11-17 2007-11-17 Personalized therapeutic treatment process WO2008064138A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CN200780050039A CN101702921A (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process
EP07864570A EP2094861A4 (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process
BRPI0719314-9A BRPI0719314A2 (en) 2006-11-17 2007-11-17 PERSONALIZED THERAPEUTIC TREATMENT PROCESS
AU2007323782A AU2007323782A1 (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process
JP2009537402A JP2010510495A (en) 2006-11-17 2007-11-17 Individual therapeutic procedures
CA002669864A CA2669864A1 (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85973906P 2006-11-17 2006-11-17
US60/859,739 2006-11-17

Publications (2)

Publication Number Publication Date
WO2008064138A2 WO2008064138A2 (en) 2008-05-29
WO2008064138A3 true WO2008064138A3 (en) 2009-01-15

Family

ID=39430529

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/085033 WO2008064138A2 (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process

Country Status (7)

Country Link
EP (1) EP2094861A4 (en)
JP (1) JP2010510495A (en)
CN (1) CN101702921A (en)
AU (1) AU2007323782A1 (en)
BR (1) BRPI0719314A2 (en)
CA (1) CA2669864A1 (en)
WO (1) WO2008064138A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0714040D0 (en) * 2007-07-19 2007-08-29 Xceleron Ltd Quantification of analytes
CN105467108A (en) * 2015-12-19 2016-04-06 开滦总医院 In-vitro determination test method for thrombolytic drug individual application dosage
US20200116657A1 (en) * 2018-10-15 2020-04-16 Olaris, Inc. Nmr-metabolite-signature for identifying cancer patients resistant to cdk4/6 inhibitors, endocrine therapy and anti-her2 therapy
EP4046161A4 (en) * 2019-10-18 2023-11-29 National University of Singapore Method for predicting a suitable therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131544A (en) * 1976-08-03 1978-12-26 Nasik Elahi Macroencapsulated sorbent element and process for using the same
US4880014A (en) * 1987-08-14 1989-11-14 Zarowitz Barbara J Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements
US20060064014A1 (en) * 2004-09-20 2006-03-23 Tony Falco Radiotherapy treatment monitoring using ultrasound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304433D0 (en) * 2003-02-27 2003-04-02 Xceleron Ltd Improvements relating to chemical libraries
AU2004227401A1 (en) * 2003-04-02 2004-10-21 Celator Pharmaceuticals, Inc. Methods to individualize combination therapy
JP5529379B2 (en) * 2004-10-28 2014-06-25 リザーランド，アルバート，エドワード Method and apparatus for separating isobaric interferences
GB0504243D0 (en) * 2005-03-02 2005-04-06 Xceleron Ltd Biological compositions labelled with radioisotope

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131544A (en) * 1976-08-03 1978-12-26 Nasik Elahi Macroencapsulated sorbent element and process for using the same
US4880014A (en) * 1987-08-14 1989-11-14 Zarowitz Barbara J Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements
US20060064014A1 (en) * 2004-09-20 2006-03-23 Tony Falco Radiotherapy treatment monitoring using ultrasound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2094861A4 *

Also Published As

Publication number Publication date
AU2007323782A1 (en) 2008-05-29
CA2669864A1 (en) 2008-05-29
WO2008064138A2 (en) 2008-05-29
JP2010510495A (en) 2010-04-02
EP2094861A4 (en) 2010-03-17
BRPI0719314A2 (en) 2014-02-04
CN101702921A (en) 2010-05-05
EP2094861A2 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
WO2010056302A3 (en) Iontophoretic therapeutic agent delivery system
WO2004087011A3 (en) Therapeutic agent delivery device with controlled therapeutic agent release rates
WO2010068866A3 (en) Therapeutic particles suitable for parenteral administration and methods of making and using same
WO2009105432A3 (en) Devices and methods for delivery of a therapeutic agent through a pneumostoma
WO2007146426A3 (en) Nanoshells for drug delivery
WO2006085115A3 (en) Therapeutic uses of tomato extracts
MXPA05003041A (en) Medical device for dispensing medicaments.
WO2007089454A3 (en) Methods for enhancing skin treatments
UA101309C2 (en) Activin-actrii antagonists thereof and uses for increasing red blood cell levels
EP2392363A3 (en) Drug coated expandable devices
MY172012A (en) Use of dpp iv inhibitors
WO2008045228A3 (en) Medical devices having porous regions for controlled therapeutic agent exposure or delivery
MX2009002196A (en) Buprenophine-wafer for drug substitution therapy.
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
EP2392364A3 (en) Rapamycin coated expandable devices
WO2009086072A3 (en) Therapy of rituximab-refractory rheumatoid arthritis patients
WO2009075879A8 (en) Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
WO2010030728A3 (en) Devices and systems for delivery of therapeutic agents to body lumens
NZ603319A (en) Diabetes therapy
WO2008003093A3 (en) Pharmaceutical compositions and related methods of treatment
WO2007081530A3 (en) Endoluminal medical device for local delivery of cathepsin inhibitors
MXPA05008461A (en) Kit for applying drug coating to a medical device in surgeon room.
RS54156B1 (en) Combinatorial therapy involving alpha5beta1 antagonists
WO2005087206A3 (en) Cancer therapy comprising a nuclear receptor ligand and a hdac inhibitor
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780050039.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07864570

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007323782

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2669864

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2009537402

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 981/MUMNP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007323782

Country of ref document: AU

Date of ref document: 20071117

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2007864570

Country of ref document: EP

ENP Entry into the national phase

Ref document number: PI0719314

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090515